Cargando…

Predictors for length of hospital stay in patients with community-acquired Pneumonia: Results from a Swiss Multicenter study

BACKGROUND: Length of hospital stay (LOS) in patients with community-acquired pneumonia (CAP) is variable and directly related to medical costs. Accurate estimation of LOS on admission and during follow-up may result in earlier and more efficient discharge strategies. METHODS: This is a prospective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suter-Widmer, Isabelle, Christ-Crain, Mirjam, Zimmerli, Werner, Albrich, Werner, Mueller, Beat, Schuetz, Philipp
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475050/ https://www.ncbi.nlm.nih.gov/pubmed/22607483 http://dx.doi.org/10.1186/1471-2466-12-21

Ejemplares similares

Hyponatremia and anti-diuretic hormone in Legionnaires’ disease
por: Schuetz, Philipp, et al.
Publicado: (2013)

Pre-analytic factors and initial biomarker levels in community-acquired pneumonia patients
por: Kutz, Alexander, et al.
Publicado: (2014)

The National Early Warning Score (NEWS) for outcome prediction in emergency department patients with community-acquired pneumonia: results from a 6-year prospective cohort study
por: Sbiti-Rohr, Diana, et al.
Publicado: (2016)

Corticosteroid treatment for community-acquired pneumonia - the STEP trial: study protocol for a randomized controlled trial
por: Blum, Claudine A, et al.
Publicado: (2014)

Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: Derivation of a clinical algorithm
por: Albrich, Werner C, et al.
Publicado: (2011)

Time-dependent association of glucocorticoids with adverse outcome in community-acquired pneumonia: a 6-year prospective cohort study
por: Nickler, Manuela, et al.
Publicado: (2017)

Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections
por: Schuetz, Philipp, et al.
Publicado: (2010)

Association of the Tyrosine/Nitrotyrosine pathway with death or ICU admission within 30 days for patients with community acquired pneumonia
por: Baumgartner, Thomas, et al.
Publicado: (2018)

Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia
por: Vögeli, Alaadin, et al.
Publicado: (2017)

Dihydrotestosterone is a predictor for mortality in males with community-acquired pneumonia: results of a 6-year follow-up study
por: Zurfluh, Seline, et al.
Publicado: (2018)

Association of Adrenal Function and Disease Severity in Community-Acquired Pneumonia
por: Mueller, Cornelia, et al.
Publicado: (2014)

Endothelin-1 precursor peptides correlate with severity of disease and outcome in patients with community acquired pneumonia
por: Schuetz, Philipp, et al.
Publicado: (2008)

Adjunct prednisone therapy for patients with community-acquired pneumonia: a randomized, placebo-controlled multicenter trial
por: Blum, CA, et al.
Publicado: (2015)

Association of the Swiss Diagnosis-Related Group Reimbursement System With Length of Stay, Mortality, and Readmission Rates in Hospitalized Adult Patients
por: Kutz, Alexander, et al.
Publicado: (2019)

Clinical predictors for Legionella in patients presenting with community-acquired pneumonia to the emergency department
por: Fiumefreddo, Rico, et al.
Publicado: (2009)

Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future
por: Schuetz, Philipp, et al.
Publicado: (2011)

Association of adrenal insufficiency with patient-oriented health-care outcomes in adult medical inpatients
por: Ebrahimi, Fahim, et al.
Publicado: (2019)

Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial
por: Schuetz, Philipp, et al.
Publicado: (2007)

Influence of Prednisone on Inflammatory Biomarkers in Community‐Acquired Pneumonia: Secondary Analysis of a Randomized Trial
por: Raess, Natalie, et al.
Publicado: (2021)

Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia
por: Müller, Beat, et al.
Publicado: (2007)

Clinical review: The role of biomarkers in the diagnosis and management of community-acquired pneumonia
por: Christ-Crain, Mirjam, et al.
Publicado: (2010)

Predictors of Length of Stay, Rehospitalization and Mortality in Community-Acquired Pneumonia Patients: A Retrospective Cohort Study
por: Lüthi-Corridori, Giorgia, et al.
Publicado: (2023)

Prognostic assessment in community-acquired pneumonia by pneumonia severity scores and biomarkers
por: Dusemund, F, et al.
Publicado: (2010)

BNP but Not s-cTnln Is Associated with Cardioembolic Aetiology and Predicts Short and Long Term Prognosis after Cerebrovascular Events
por: Nigro, Nicole, et al.
Publicado: (2014)

Infection biomarkers in primary care patients with acute respiratory tract infections–comparison of Procalcitonin and C-reactive protein
por: Meili, Marc, et al.
Publicado: (2016)

Prognostic Value of Dehydroepiandrosterone-Sulfate and Other Parameters of Adrenal Function in Acute Ischemic Stroke
por: Blum, Claudine A., et al.
Publicado: (2013)

SAT-066 Effect Of Interleukin-1-receptor Antagonist On Hemodynamics And Renin-angiotensin-aldosterone System In Obese Individuals
por: Urwyler, Sandrine, et al.
Publicado: (2019)

Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome
por: Ebrahimi, Fahim, et al.
Publicado: (2021)

Effectiveness of Proadrenomedullin Enhanced CURB65 Score Algorithm in Patients with Community-Acquired Pneumonia in “Real Life”, an Observational Quality Control Survey
por: Widmer, Daniel, et al.
Publicado: (2014)

Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhage
por: Zweifel, Christian, et al.
Publicado: (2010)

Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]
por: Christ-Crain, Mirjam, et al.
Publicado: (2006)

Circulating Precursor Levels of Endothelin-1 and Adrenomedullin, Two Endothelium-Derived, Counteracting Substances, in Sepsis
por: Schuetz, Philipp, et al.
Publicado: (2007)

No obesity paradox in patients with community-acquired pneumonia – secondary analysis of a randomized controlled trial
por: Borisov, Angel N., et al.
Publicado: (2022)

Effects of interleukin-1 antagonism on cortisol levels in individuals with obesity: a randomized clinical trial
por: Ebrahimi, Fahim, et al.
Publicado: (2019)

Multidisciplinary Assessment to Personalize Length of Stay in Acute Decompensated Heart Failure (OPTIMA II ADHF)
por: Dusemund, Frank, et al.
Publicado: (2012)

Corticosteroids for all adult patients with community-acquired pneumonia?
por: Spoorenberg, Simone M. C., et al.
Publicado: (2015)

Pro-Adrenomedullin predicts 10-year all-cause mortality in community-dwelling patients: a prospective cohort study
por: Odermatt, Jonas, et al.
Publicado: (2017)

Copeptin levels and commonly used laboratory parameters in hospitalised patients with severe hypernatraemia - the “Co-MED study”
por: Nigro, Nicole, et al.
Publicado: (2018)

Risk of Adverse Clinical Outcomes in Hyponatremic Adult Patients Hospitalized for Acute Medical Conditions: A Population-Based Cohort Study
por: Kutz, Alexander, et al.
Publicado: (2020)

The Impact of Drug Interactions in Patients with Community-Acquired Pneumonia on Hospital Length of Stay
por: Schmitt, Johannes Peter, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4ctn1vsv44lc2kkaeg3564galg